title: [beta-Blockers as adjuvant therapy in delirium tremens (author's transl)].
abstract: Tachycardia in delirium tremens is often not adequately controlled by present delirium therapy but it can be treated with beta-receptor blockers. The favorable effect on the disorder expressed as adrenergic tachycardia due to raised excretion of catecholamine during delirium tremens is shown by pindolol (Visken) in a series of 14 patients. A favorable effect on the hypertensive circulatory condition in delirium tremens was also shown by certain ECG changes beyond those of tachycardia. In one case, a severe anaphylactic reaction occurred after the i. v. application of pindolol. No other side-effects were observed.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy*; D006801:Humans; D010869:Pindolol / Q000627:therapeutic use; D011604:Psychoses, Alcoholic / Q000188:drug therapy*; D013610:Tachycardia / Q000188:drug therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D010869:Pindolol
vernacular_title: Ein Beta-Blocker als Zusatztherapie beim Delirium tremens.